Case Report: Disease progression of renal cell carcinoma containing a novel putative pathogenic KAT6A::NRG1 fusion on Ipilimumab- Nivolumab immunotherapy. A case study and review of the literature

Renal cell carcinoma still carries a poor prognosis despite therapeutic advancements. Detection of genetic mutations is vital in improving our understanding of this disease as well as potential role in targeted therapy. Here we present a case of a 49 year old man with an aggressive renal cell carcin...

Descripción completa

Detalles Bibliográficos
Autores principales: Dawood, Almas, MacMahon, Suzanne, Dang, My-Anh Tran, Tran, Maxine G. B., Bex, Axel, Boleti, Ekaterini, Sheikh, Soha El
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932956/
https://www.ncbi.nlm.nih.gov/pubmed/36816927
http://dx.doi.org/10.3389/fonc.2023.1111706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932956/
https://www.ncbi.nlm.nih.gov/pubmed/36816927
http://dx.doi.org/10.3389/fonc.2023.1111706

Ejemplares similares